v3.26.1
Consolidated Statement of Cash Flows - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flow from / (used in) operating activities    
Net profit / (loss) $ 5,866 $ 4,105
Non-cash items included in net profit and other adjustments:    
Depreciation, amortization and impairment of non-financial assets 1,540 1,759
Credit loss expense / (release) 191 263
Share of net (profit) / loss of associates and joint ventures and impairment related to associates (110) (157)
Deferred tax expense / (benefit) 550 (607)
Net loss / (gain) from investing activities (81) (153)
Net loss / (gain) from financing activities 2,404 13,603
Other net adjustments 5,028 (31,208)
Net change in operating assets and liabilities:    
Amounts due from banks and amounts due to banks 3,337 6,953
Receivables from securities financing transactions measured at amortized cost (982) 14,925
Payables from securities financing transactions measured at amortized cost 2,610 1,509
Cash collateral on derivative instruments (6,790) (3,533)
Loans and advances to customers (19,579) (7,214)
Customer deposits 5,829 (1,952)
Financial assets and liabilities at fair value held for trading and derivative financial instruments 1,088 33,794
Brokerage receivables and payables 7,287 5,294
Financial assets at fair value not held for trading and other financial assets and liabilities (478) (11,885)
Provisions and other non-financial assets and liabilities 1,032 (3,275)
Income taxes paid, net of refunds (686) (1,331)
Net cash flow from / (used in) operating activities 8,054 20,889
Cash flow from / (used in) investing activities    
Purchase of subsidiaries, business, associates and intangible assets   (17)
Disposal of subsidiaries, business, associates and intangible assets 560 482
Purchase of property, equipment and software (1,160) (1,109)
Disposal of property, equipment and software 81 62
Purchase of financial assets measured at fair value (3,879) (7,175)
Disposal and redemption of financial assets measured at fair value 3,071 2,772
Purchase of debt securities measured at amortized cost (7,939) (14,792)
Disposal and redemption of debt securities measured at amortized cost 8,038 5,625
Net cash flow from / (used in) investing activities (1,227) (14,150)
Cash flow from / (used in) financing activities    
Net issuance (repayment) of short-term debt measured at amortized cost 10,526 3,002
Net movements in treasury shares and own equity derivative activity (3,189) (2,073)
Distributions paid on UBS Group AG shares (3,404) (2,866)
Issuance of debt designated at fair value and long-term debt measured at amortized cost 84,271 61,836
Repayment of debt designated at fair value and long-term debt measured at amortized cost (81,180) (71,129)
Inflows from securities financing transactions measured at amortized cost 1,736 565
Outflows from securities financing transactions measured at amortized cost   (1,561)
Net cash flows from other financing activities (400) (544)
Net cash flow from / (used in) financing activities 8,361 (12,769)
Total cash flow    
Cash and cash equivalents at the beginning of the period 231,375 244,090
Net cash flow from / (used in) operating, investing and financing activities 15,188 (6,030)
Effects of exchange rate differences on cash and cash equivalents (3,888) 20,992
Cash and cash equivalents at the end of the period 242,675 259,052
of which: cash and balances at central banks 215,716 236,193
of which: amounts due from banks 19,629 19,821
of which: money market paper 7,330 3,039
Net cash flow from / (used in) operating activities includes:    
Interest received in cash 20,367 21,679
Interest paid in cash 15,647 19,062
Dividends on equity investments, investment funds and associates received in cash $ 1,332 $ 1,803